In addition, some lncRNAs, such as small nucleolar RNA hostgene 11 (SNHG11), HOXC cluster antisense RNA 1 (HOXC-AS1), and DLGAP1 antisense RNA 2 (DLGAP1-AS2), have also been found to regulate the expression of the key components in the Wnt/β-catenin signaling pathway during GC progression (20, 118–120), indicating that they may also influence the development of drug resistance in GC by targeting the Wnt/β-catenin pathway. This evidence concerns the gene SNHG11 and gastric cancer.